Testing effectiveness (Phase 2)Study completedNCT01643330
What this trial is testing
Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Who this might be right for
Ischemic CardiomyopathyNon-ischemic CardiomyopathyHeart Failure+1 more
Celladon Corporation 250